Intelligent Investor

Adherium Limited (ASX: ADR) - Announcements

Current share price for ADR : $0.029 0.001 (3.57%)

ASX company news and announcements for Adherium Limited (ADR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Adherium Limited (ADR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Adherium Limited (ADR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Adherium Limited (ADR)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$10 Disclosure of Long Equity Derivative Positions 18 Apr 2024 2:35PM $0.031 $0.029 $0.040 fallen by 6.45%
$10 Notification regarding unquoted securities - ADR 17 Apr 2024 6:01PM $0.031 $0.029 $0.040 fallen by 6.45%
$10 Application for quotation of securities - ADR 17 Apr 2024 5:56PM $0.031 $0.029 $0.040 fallen by 6.45%
$10 US FDA clearance of Hailie for AstraZeneca inhalers 15 Apr 2024 9:48AM $0.040 $0.029 $0.040 fallen by 27.50%
$10 Change of Director Interest Notices x 2 - Expiry of Options 4 Apr 2024 6:02PM $0.045 $0.029 $0.040 fallen by 35.56%
$10 Rimidi Partnership for Respiratory Clinical Management 3 Apr 2024 10:09AM $0.043 $0.029 $0.040 fallen by 32.56%
$10 Notification of cessation of securities - ADR 2 Apr 2024 8:23AM $0.042 $0.029 $0.040 fallen by 30.95%
$10 Change in substantial holding 27 Mar 2024 7:22PM $0.042 $0.029 $0.040 fallen by 30.95%
$10 First Patient Enrolled in Major e-health Clinical Study 20 Mar 2024 9:38AM $0.041 $0.029 $0.040 fallen by 29.27%
$10 Adherium receives $1.5m Australian R&D Tax Rebate 7 Mar 2024 10:01AM $0.042 $0.029 $0.040 fallen by 30.95%
$10 Alliance Tech Medical Partnership to expand US product reach 29 Feb 2024 12:38PM $0.042 $0.029 $0.040 fallen by 30.95%
$10 Half Yearly Report and Accounts 29 Feb 2024 9:38AM $0.042 $0.029 $0.040 fallen by 30.95%
$10 Adherium Exhibiting at AAAAI 2024 Annual Meeting 22 Feb 2024 9:31AM $0.045 $0.029 $0.040 fallen by 35.56%
$10 New CEO Appointed - Dr Paul Mastoridis 1 Feb 2024 9:36AM $0.045 $0.029 $0.040 fallen by 35.56%
$10 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2024 8:44AM $0.051 $0.029 $0.040 fallen by 43.14%
$10 Resignation of CEO 16 Jan 2024 9:02AM $0.062 $0.029 $0.040 fallen by 53.23%
$10 Change of Company Address 10 Jan 2024 5:40PM $0.062 $0.029 $0.040 fallen by 53.23%
$10 Partnership with NuvoAir Medical to Enhance Patient Outcomes 10 Jan 2024 12:00PM $0.062 $0.029 $0.040 fallen by 53.23%
$10 First Order of Hailie Sensors to US Intermountain Health 18 Dec 2023 9:53AM $0.032 $0.029 $0.040 fallen by 9.38%
$10 Completion of Share Consolidation 7 Dec 2023 2:10PM $0.027 $0.029 $0.040 risen by 7.41%
$10 Production and US Market Release of Advanced Smartinhaler 4 Dec 2023 12:51PM $0.003 $0.029 $0.040 risen by 866.67%
$10 Securities Incentive Plan 1 Dec 2023 5:51PM $0.003 $0.029 $0.040 risen by 866.67%
$10 Amended Constitution 1 Dec 2023 5:27PM $0.003 $0.029 $0.040 risen by 866.67%
$10 Results of Meeting & Approval of Share Consolidation 30 Nov 2023 1:48PM $0.003 $0.029 $0.040 risen by 866.67%
$10 CEO Presentation to the Annual General Meeting 30 Nov 2023 9:58AM $0.003 $0.029 $0.040 risen by 866.67%

1 - 25 of 629 results

Page 1 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.